Pleural pressure measurement in malignant pleural effusion
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a procedure called pleural manometry, which measures pressure in the chest during fluid drainage, to see if it helps doctors better assess and treat malignant pleural effusion (fluid buildup around the lung caused by cancer). The goal is to improve symptom relief and treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer and a pleural effusion (fluid around the lung) that is causing symptoms.
- The fluid must be confirmed as malignant by testing, or it's a recurring fluid buildup without another clear cause, or linked to thickened pleura on a scan.
- Your lung must be able to fully expand (no non-expandable lung on imaging).
- You must have a life expectancy of at least one month.
- You have not had previous surgery, chemotherapy, or radiation on the same side as the effusion.
- You are not pregnant, have no bleeding problems, and can tolerate sedation or anesthesia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two ways to manage a buildup of fluid around the lung caused by cancer. One method uses a temporary tube to drain the fluid, and the other uses a procedure to seal the space so fluid does not come back. The goal is to see which approach helps people breathe more easily and feel better.
This trial tests a new drug given directly into the chest cavity to treat fluid buildup caused by non-small cell lung cancer. It may help ease breathing problems and control the fluid.
This study tests whether a thin, flexible tube (like a small camera) can safely and effectively help doctors get tissue samples from fluid around the lung. It compares a single-use flexible tool to a standard semi-rigid scope, and may help find the cause of your lung fluid.
This trial tests an investigational drug called JMKX000197 given into the chest to control fluid buildup caused by cancer. It is for people with advanced solid tumors that have led to a moderate or large pleural effusion requiring drainage.
This study collects fluid that builds up around your lungs (pleural effusion) during a drainage procedure you already need. Researchers test how different drugs affect your cancer cells in the lab to help predict which treatments might work best for you.
This trial tests a new drug called JMKX000197 against a standard chemotherapy drug (cisplatin) to see which is better at reducing fluid buildup around the lungs in people with advanced cancer. The goal is to ease breathing and improve quality of life.
Hear when a new Malignant Pleural Effusions (Mpe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.